![](https://SOULREST.ORG/image/144.jpg)
WEIGHT: 55 kg
Bust: 36
1 HOUR:140$
Overnight: +90$
Services: Facial, Facial, Moresomes, Swinging, Fetish
Colorectal cancer CRC βthe third most common cancer in the UK and the second leading cause of cancer mortalityβis a heterogeneous disease comprising distinct molecular subgroups that differ in their histopathological features, prognosis, and response to therapy.
Despite advances in the detection and treatment of early-stage disease, patients with advanced, recurrent, or metastatic CRCs have few therapeutic options and a dismal prognosis.
Utilising state-of-the-art preclinical models harbouring key driver mutations, our group is interrogating the molecular mechanisms underpinning CRC initiation, progression, response to therapy, and metastasis.
Our overarching goals are to identify early-stage diagnostic biomarkers and develop stage- and subtype-specific targeted therapies. As part of these efforts, we are major contributors to a number of large cancer consortia, with the aim of driving more effective therapeutic approaches in colorectal cancer.
Our group leads a Europe-wide, CRUK-funded consortium of basic, translational, and clinical scientists ACRCelerateβColorectal Cancer Stratified Medicine Network to identify new therapeutic targets for the different CRC subtypes and deliver molecular insights with the potential to inform clinical decision-making and patient stratification.